SEC Form 4 · accession 0000899243-17-002790
Sorrento Therapeutics, Inc. · SRNE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kim Janda
Director
Period of report
Feb 3, 2017
Accepted (ET)
Feb 3, 2017 · 7:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 3, 2017 | P | 3,000 | $5.15 | A | 3,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24- Power of Attorney